Indications, evaluation and treatment Rajabrata Sarkar M.D. Ph.D. - - PDF document

indications evaluation and
SMART_READER_LITE
LIVE PREVIEW

Indications, evaluation and treatment Rajabrata Sarkar M.D. Ph.D. - - PDF document

4/4/2019 Iliac vein interventions: Indications, evaluation and treatment Rajabrata Sarkar M.D. Ph.D. Barbara Baur Dunlap Professor of Surgery and Physiology Interim Chair, Dept. of Surgery Chief, Division of Vascular Surgery University of


slide-1
SLIDE 1

4/4/2019 1

Iliac vein interventions: Indications, evaluation and treatment

Rajabrata Sarkar M.D. Ph.D. Barbara Baur Dunlap Professor of Surgery and Physiology Interim Chair, Dept. of Surgery Chief, Division of Vascular Surgery University of Maryland

Disclosures

None Off label use of stents in iliac veins

1 2

slide-2
SLIDE 2

4/4/2019 2

Classification of venous disease

3 4

slide-3
SLIDE 3

4/4/2019 3

Complications of DVT

1 million new DVT patients/year in USA 25-65% of those with proximal DVT will develop post- thrombotic syndrome within 2- 3 years Severe post-thrombotic syndrome is highly disabling Anticoagulation does not prevent post-thrombotic syndrome

Iliac vein interventions: Indications

  • Acute DVT?
  • ATTRACT trial results negative for

prevention of post-thrombotic syndrome

  • Vendantham, NEJM 2017
  • Phlegmasia (IVC filter thrombosis)
  • Post-op kidney/pancreas transplant (rare)
  • Chronic venous insufficiency

5 6

slide-4
SLIDE 4

4/4/2019 4

ATTRACT trial

  • NIH-funded multicenter trial that randomized 692

pts with iliofemoral DVT to either anticoagulation

  • r pharmacomechanical thrombectomy plus

anticoagulation

  • At 2 years, no difference in post-thrombotic

syndrome (47% vs. 48%)

  • Increased bleeding (non-fatal) in the

thrombectomy group (1.7% vs. 0.3%)

  • Decreased enthusiasm for intervention for acute

iliofemoral DVT for prophylaxis

  • Vendantham, NEJM 2017

Caval Thrombosis

  • Almost always seen in setting of prior IVC

filter

  • Only 8% of retrievable filters are actually

retrieved nationally

  • Predisposes to extensive ileocaval

thrombosis

  • Patients very symptomatic and may have

phlegmasia, renal dysfunction, etc.

7 8

slide-5
SLIDE 5

4/4/2019 5

Caval thrombosis Caval thrombosis: approach

  • Consider second suprarenal filter if thrombus extends

through existing filter

  • Pharmocomechanical rather than purely pharmacologic

thrombectomy (large thrombus burden, severe symptoms)

  • Re-establish some flow channel from groin through filter
  • Accept residual thrombus in IVC/filter rather than

prolonged TPA therapy

  • Effective anticoagulation (LMWH) and hydration

essential to prevent early rethrombosis

9 10

slide-6
SLIDE 6

4/4/2019 6

Caval thrombosis Caval thrombosis

11 12

slide-7
SLIDE 7

4/4/2019 7

Caval thrombosis Caval thrombosis

13 14

slide-8
SLIDE 8

4/4/2019 8

Caval thrombosis Caval thrombosis

15 16

slide-9
SLIDE 9

4/4/2019 9

Post-transplant iliac DVT

  • Can present days to years after kidney or

pancreas transplant

  • Often associated with graft dysfunction

(elevated Cr) and mild unilateral edema

  • Graft dysfunction normalizes with

restoration of venous outflow

  • Aggressive approach to correcting

underlying venous stenosis (iliac, caval) to prevent recurrence

Post-transplant iliac DVT: iliac stent

Khalifeh, J Vasc Surg Cases Innov Tech. 2019 Mar; 5(1): 7–11.

17 18

slide-10
SLIDE 10

4/4/2019 10

Post-transplant iliac DVT: May- Thurner

Khalifeh, J Vasc Surg Cases Innov Tech. 2019 Mar; 5(1): 7–11.

Post-transplant iliac DVT: IVC filter thrombosis

Khalifeh, J Vasc Surg Cases Innov Tech. 2019 Mar; 5(1): 7–11.

19 20

slide-11
SLIDE 11

4/4/2019 11

Chronic venous ulcers

Conventional treatments not effective compression therapy, perforator ligation, etc. Few pts with post-thrombotic ulcers have correctable reflux Leads to a nihilistic outlook for patients based on irreversible loss of valve function

Advances in care of Post- thrombotic syndrome

Unexpected major role for venous stenting in deep reflux disease

S Raju, J Vasc Surg, 2010

504 patients with reflux (54% post DVT) 37% had normal venogram but all had >50% stenosis by intravascular ultrasound 88% free from ulcers at 5 yrs. 2009 SVS discussion: “challenges all the previous concepts of pathogenesis and treatment of chronic venous insufficiency”

21 22

slide-12
SLIDE 12

4/4/2019 12

Chronic venous disease

Fundamental paradigm shift towards proximal

  • bstructive lesions in post-thrombotic and

non-thrombotic patients (S. Raju) Importance of intravascular ultrasound over

  • ther modalities (CT, venogram, etc.)

Small differences in area (50%) can cause symptoms Small improvements in area (50-75%) can heal ulcers

Diagnostic IVUS Pullback

24

Nonthrombotic Iliac Vein Lesion in Proximal Common Iliac Vein Tightest Stenosis = 69.8 mm2

  • Reference Area = 216.7 mm2

Pre-Treatment Reduction

  • f Cross-Sectional Area = 68%

Approximate Lesion Length = 4.5 cm

601-0100.93/001

https://clinicaltrials.gov/ct2/show/NCT02142062 Venogram vs. Intravascular Ultrasound (IVUS) for Diagnosing Iliac Vein Obstruction (VIDIO) Case details , images, and footage courtesy of Robert Tahara, MD. Dr. Tahara is the investigator of VIDIO, a Volcano sponsored study. Results from this case study are not predictive of future results. Data on file at Volcano clinical affairs department.

23 24

slide-13
SLIDE 13

4/4/2019 13

Iliac Vein

Treatment Informed by IVUS Findings

Left Common Iliac Vein Tightest Stenosis Post-Stenting Left Common Iliac Vein Tightest Stenosis Pre-Stenting

Pre-Treatment Tightest Stenosis = 69.8 mm2 Treated with two 18 x 90 mm Overlapping Stents, extending into IVC Post-Treatment Cross-Sectional Area = 179.5 mm2 Luminal Gain of 110mm2 or 157%

25

601-0100.93/001

https://clinicaltrials.gov/ct2/show/NCT02142062 Venogram vs. Intravascular Ultrasound (IVUS) for Diagnosing Iliac Vein Obstruction (VIDIO) Case details , images, and footage courtesy of Robert Tahara, MD. Dr. Tahara is the investigator of VIDIO, a Volcano sponsored study. Results from this case study are not predictive of future results. Data on file at Volcano clinical affairs department.

  • 68 year old male

with severe bilateral venous ulcers (circumferential)

  • S/P bilateral DVT,

numerous procedures for superficial reflux

  • Weekly Unaboot

changes in clinic for 3 years by me,

  • 5 years by my

partners before

R Hussein. Chronic Venous Ulcers An End Of Long Term Suffering. The Internet Journal of Plastic Surgery. 2007 Volume 5 Number 1.

25 26

slide-14
SLIDE 14

4/4/2019 14 “Poor opacification of the iliac veins limits assessment of

  • thrombus. Possible compression of left iliac vein by

artery”

27 28

slide-15
SLIDE 15

4/4/2019 15

Evaluation of venous ulcers

  • Rule out arterial disease
  • Wound care
  • Nutrition evaluation
  • Venous duplex examination with reflux
  • Iliac venogram or ablation of reflux first?

29 30

slide-16
SLIDE 16

4/4/2019 16

Evaluation of venous ulcers

  • Treated GSV reflux when diameter > 5 mm
  • Otherwise iliac venogram and stenting of

all lesions >50% decrease in area

  • All patients with ulcer and leg swelling

received iliac venogram

  • How does iliac vein stenting compare with

saphenous ablation?

  • Raju S, J Vasc Surg Venous Lymphat
  • Disord. 2013 Apr;1(2):165-72

31 32

slide-17
SLIDE 17

4/4/2019 17

Technical Points

  • Puncture femoral vein or GSV mid-thigh or

lower, not common femoral vein to keep tip

  • f sheath low enough to allow stenting

down to common femoral vein

  • Know normal sizes of external and

common iliac veins to identify long tubular stenosis or chronically shrunken veins

  • Unlike arterial disease, stent into common

femoral vein if needed

33 34

slide-18
SLIDE 18

4/4/2019 18

35 36

slide-19
SLIDE 19

4/4/2019 19

37 38

slide-20
SLIDE 20

4/4/2019 20

Iliac interventions: Followup

  • Postoperative ASA+clopidigrel for 90 days

then ASA 81 mg only

  • IVC/iliac Duplex and office visit every six

months

  • Encourage stocking use, exercise and

weight loss

  • For ulcers, aggressive wound care (referral

to wound care center)

39 40

slide-21
SLIDE 21

4/4/2019 21

41